Patents Assigned to QUANTUMDX GROUP LIMITED
  • Patent number: 12269034
    Abstract: Improved methods and devices using reduction of pressure for removing ethanol from filters in a fluidic or microfluidic system in point of care devices involve filters that are solid state extraction filters used to capture and/or concentrate nucleic acids prior to further downstream processing such as amplification by polymerase chain reaction. The method uses the induction of negative pressure with respect to atmospheric pressure to improve the efficiency of the ethanol removal process.
    Type: Grant
    Filed: November 28, 2019
    Date of Patent: April 8, 2025
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Hojjat Madadi, Robin Page, Molly Rose Jowsey, Thomas Michael Willshare, Roberts Rimsa
  • Patent number: 12179200
    Abstract: Microfluidic device having a plurality of microfluidic channels and corresponding dielectrophoresis (DEP) electrode arrays, each channel arranged to direct fluid over a DEP electrode array such that in use target particles are manipulated by the DEP electrode array. The device also has a first connection point and second connection point for connecting the device to an alternating current source, a first input of each DEP electrode array connected to the first connection point via the first conductor and second input of each DEP electrode array connected to the second connection point via the second conductor. A resistance of the first conductor between the first input of each electrode and the first connection point, and a resistance of the second conductor between the second input of each electrode and the second connection point is substantially at least an order of magnitude less than a total resistance of the connected electrode arrays.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: December 31, 2024
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Heather Murton, Lothar Schmid, Eduardo Boada
  • Patent number: 12134094
    Abstract: An interface for a microfluidic device such as a microfluidic cassette has a seal portion moveable from a first position to a second position within a reservoir in response to an applied force. Movement of the seal portion within the reservoir causes the volume of the reservoir to increase. The interface also has a hollow needle with a first end and a second end, the first end locatable in fluid communication with the reservoir and the second end located outside of the reservoir and arranged for piercing. The seal portion and the needle are arranged such that when the seal portion moves from the first position to the second position, a predetermined volume of fluid is drawn through the needle into the reservoir.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: November 5, 2024
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: James Bennett, Neil Litten, Richard Smith, Julian Brandon-Jones
  • Patent number: 12128412
    Abstract: A specimen container has a vessel having a reservoir and a specimen collection region. The specimen container also has a sleeve located within the vessel and moveable in the direction of the reservoir. Movement of the sleeve in the direction of the reservoir results in the specimen collection region and reservoir being brought into fluid communication with each other.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: October 29, 2024
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: James Bennett, Neil Litten, Richard Smith, Julian Brandon-Jones
  • Patent number: 11850593
    Abstract: Methods and devices for concentrating target cells using dielectrophoresis (DEP) are disclosed. The method allows relatively high throughput of sample through a microfluidic device in order to allow rapid capture of target cells even when they are present in low concentrations within the sample. The method utilizes multiple chambers through which samples will flow, the chambers arranged such that the first capture area has a larger area and faster flow rate than a second chamber, the second chamber being positioned downstream of the first capture area and being smaller with a slower flow rate to further concentrate the material captured in the first capture area.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: December 26, 2023
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan O'Halloran, Heather Murton, Stephen Osborne, Eduardo Boada, Jonathan Salmon
  • Patent number: 11596944
    Abstract: A microfluidics device has one or more bubble diversion regions. Problems associated with the generation of air bubbles are avoided in a microfluidics device such as a cartridge, for use with a point of care (POC) diagnostics device, the cartridge being able to carry out downstream processing such as polymerase chain reaction (PCR) and/or nucleic acid capture. The bubble diversion region has a lower flow resistance than the flow resistance of an area of interest.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: March 7, 2023
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Hojjat Madadi, Thomas Michael Willshare, Jonathan O'Halloran, Philip Thomas Scully, Paul Marshall, Eduardo Boada
  • Patent number: 11180523
    Abstract: Embodiments of the present disclosure relate generally to reporter compositions which are synthetic nucleotides that comprise nucleotides with a high charge mass moiety attached thereto via a linker molecule. The linker molecules can vary in length in part to enable the high charge mass moiety to extend out from a DNA polymerase complex so that polymerization may not be influenced.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: November 23, 2021
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan J. O'Halloran, Joseph H. Hedley
  • Patent number: 10792640
    Abstract: A sorbent material is disclosed for the one-step separation of bio-macromolecules in a single pass extraction of DNA from complex mixtures of molecules and chemicals. In one embodiment, the sorbent material comprises a silanized material at least partially coated or formed with a polymer selected from the group consisting of a poly(aryl methacrylate), a poly(aryl acrylate), a poly(heteroaryl methacrylate, a poly(heteroaryl acrylate) and a copolymer thereof.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: October 6, 2020
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan James O'Halloran, Joseph H. Hedley, Sam Whitehouse, Marc Flanagan, John Tyson, Rachael Dixon, Sam Bhatt, Emily Crozier, Chris Howell
  • Patent number: 10759824
    Abstract: Embodiments of the present disclosure relate generally to reporter compositions which are synthetic nucleotides that comprise nucleotides with a high charge mass moiety attached thereto via a linker molecule. The linker molecules can vary in length in part to enable the high charge mass moiety to extend out from a DNA polymerase complex so that polymerization may not be influenced.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: September 1, 2020
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan O'Halloran, Joseph H. Hedley
  • Patent number: 10710075
    Abstract: Methods and devices for concentrating target cells using dielectrophoresis (DEP) are disclosed. The method allows relatively high throughput of sample through a microfluidic device in order to allow rapid capture of target cells even when they are present in low concentrations within the sample. The method utilizes multiple chambers through which samples will flow, the chambers arranged such that the first capture area has a larger area and faster flow rate than a second chamber, the second chamber being positioned downstream of the first capture area and being smaller with a slower flow rate to further concentrate the material captured in the first capture area.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: July 14, 2020
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan O'Halloran, Heather Murton, Stephen Osborne, Eduardo Boada, Jonathan Salmon
  • Publication number: 20190176151
    Abstract: Methods and devices for concentrating target cells using dielectrophoresis (DEP) are disclosed. The method allows relatively high throughput of sample through a microfluidic device in order to allow rapid capture of target cells even when they are present in low concentrations within the sample. The method utilizes multiple chambers through which samples will flow, the chambers arranged such that the first capture area has a larger area and faster flow rate than a second chamber, the second chamber being positioned downstream of the first capture area and being smaller with a slower flow rate to further concentrate the material captured in the first capture area.
    Type: Application
    Filed: June 20, 2017
    Publication date: June 13, 2019
    Applicant: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan O'HALLORAN, Heather MURTON, Stephen OSBORNE, Eduardo BOADA, Jonathan SALMON
  • Patent number: 10273261
    Abstract: Embodiments of the present disclosure relate generally to reporter compositions which are synthetic nucleotides that comprise nucleotides with a high charge mass moiety attached thereto via a linker molecule. The linker molecules can vary in length in part to enable the high charge mass moiety to extend out from a DNA polymerase complex so that polymerization may not be influenced.
    Type: Grant
    Filed: January 3, 2017
    Date of Patent: April 30, 2019
    Assignee: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan J. O'Halloran, Joseph H. Hedley
  • Patent number: 9938573
    Abstract: Various embodiments of the present disclosure generally relate to molecular biological protocols, equipment and reagents for the sequencing of target nucleic acid (DNA, RNA, cDNA, etc) molecules.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: April 10, 2018
    Assignee: QUANTUMDX GROUP LIMITED
    Inventor: Jonathan O'Halloran
  • Publication number: 20170282154
    Abstract: A sorbent material is disclosed for the one-step separation of bio-macromolecules in a single pass extraction of DNA from complex mixtures of molecules and chemicals. In one embodiment, the sorbent material comprises a silanized material at least partially coated or formed with a polymer selected from the group consisting of a poly(aryl methacrylate), a poly(aryl acrylate), a poly(heteroaryl methacrylate, a poly(heteroaryl acrylate) and a copolymer thereof.
    Type: Application
    Filed: September 10, 2015
    Publication date: October 5, 2017
    Applicant: QuantuMDx Group Limited
    Inventors: Jonathan James O'HALLORAN, Joseph H. HEDLEY, Sam WHITEHOUSE, Marc FLANAGAN, John TYSON, Rachael DIXON, Sam BHATT, Emily CROZIER, Chris HOWELL
  • Patent number: 9605302
    Abstract: Embodiments of the present invention relate generally to strategies and methods of amplifying short target sequences and removing flanking sequences from target nucleic acids to remove background signal when detecting hybridizations events using sensitive detection biosensors, such as biosensors based on nanowires, carbon nanotubes, nanopores etc, that may be capable of detecting molecules at small molar concentrations (fM and less), or even at the single molecule level. Furthermore, by cropping and therefore standardizing the size of the target sequences to be detected, when detecting many target sequences in an array, the signals across each biosensor can be compared and the hybridization conditions standardized easily.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: March 28, 2017
    Assignee: QuantuMDx Group Limited
    Inventor: Jonathan O'Halloran
  • Patent number: 9410196
    Abstract: Various embodiments of the present disclosure generally relate to molecular biological protocols, equipment and reagents for the sequencing of target nucleic acid (DNA, RNA, cDNA, etc) molecules.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: August 9, 2016
    Assignee: QUANTUMDX GROUP LIMITED
    Inventor: Jonathan O'Halloran
  • Publication number: 20150276709
    Abstract: Various embodiments of the present disclosure generally relate to molecular biological protocols, equipment and reagents for the sequencing of long individual polynucleotide molecules.
    Type: Application
    Filed: August 5, 2013
    Publication date: October 1, 2015
    Applicant: QuantuMDx Group Limited
    Inventors: Jonathan O'Halloran, Christopher Adams, Joseph H. Hedley, Sam Whitehouse
  • Publication number: 20140206562
    Abstract: Fabrication of a microfluidic multi-temperature reaction device (MMR) and the design and fabrication of the equipment to drive various molecular biological methods on the device are provided. The device can be applicable, for example, to nucleic acid (DNA, RNA, cDNA, etc) amplification, cell lysis, reverse transcription and other enzymatic temperature sensitive and also temperature cycling reactions.
    Type: Application
    Filed: January 20, 2014
    Publication date: July 24, 2014
    Applicant: QUANTUMDX GROUP LIMITED
    Inventors: JOHN EDWARD MCCORMACK, ELAINE HARRINGTON WARBURTON, JONATHAN JAMES O'HALLORAN, MATTHEW DANIEL SOLOMON, DAVID JAMES BRIGGS, MINDY LEE ANDRE, MATTHIAS SCHUENEMANN
  • Publication number: 20140179909
    Abstract: Various embodiments of the present disclosure generally relate to molecular biological protocols, equipment and reagents for the extraction and fractionation of DNA molecules, from whole or lysed samples, in a single flow-through device.
    Type: Application
    Filed: November 30, 2011
    Publication date: June 26, 2014
    Applicant: QUANTUMDX GROUP LIMITED
    Inventors: Jonathan James O'Halloran, Elaine Harrington Warburton, Matthew Daniel Solomon, John Edward McCormack, Matthias Schuenemann, David James Briggs, Mindy Lee Andre
  • Publication number: 20110294685
    Abstract: Embodiments of the present invention relate generally to strategies and methods of amplifying short target sequences and removing flanking sequences from target nucleic acids to remove background signal when detecting hybridizations events using sensitive detection biosensors, such as biosensors based on nanowires, carbon nanotubes, nanopores etc, that may be capable of detecting molecules at small molar concentrations (fM and less), or even at the single molecule level. Furthermore, by cropping and therefore standardizing the size of the target sequences to be detected, when detecting many target sequences in an array, the signals across each biosensor can be compared and the hybridization conditions standardized easily.
    Type: Application
    Filed: September 3, 2009
    Publication date: December 1, 2011
    Applicant: QUANTUMDX GROUP LIMITED
    Inventor: Jonathan O'Halloran